Literature DB >> 12769342

Vaccination against infections in chronic lymphocytic leukemia.

Marjatta Sinisalo1, Janne Aittoniemi, Helena Käyhty, Juhani Vilpo.   

Abstract

Chronic lymphocytic leukemia (CLL) is a well-defined mature B-cell neoplasm associated with increased susceptibility to infections. Two major options in prevention of infections in CLL, intravenous gammaglobulin treatment and antimicrobial chemoprophylaxis, have not resulted in satisfactory outcome. A third strategy, antimicrobial vaccination, is the topic of this minireview. We collected articles and their references concerning CLL vaccination from the Medline database starting from 1966 and thirteen relevant studies were found. Plain bacterial polysaccharide vaccines would seem to be ineffective in antibody formation in patients with CLL. However, protein and conjugate vaccines appear to be more immunogenic and their responses may be further enhanced with ranitidine adjuvant treatment. New well-designed investigations are needed to develop appropriate vaccination strategies and evaluate vaccination efficacy in infection morbidity and mortality in CLL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769342     DOI: 10.1080/1042819031000063408

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  14 in total

1.  Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.

Authors:  Dorothea Evers; Jaap Jan Zwaginga; Janneke Tijmensen; Rutger A Middelburg; Masja de Haas; Karen M K de Vooght; Daan van de Kerkhof; Otto Visser; Nathalie C V Péquériaux; Francisca Hudig; Johanna G van der Bom
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

Review 2.  A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.

Authors:  S Lachance; A L Christofides; J K Lee; L H Sehn; B C Ritchie; C Shustik; D A Stewart; C L Toze; E Haddad; D C Vinh
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 3.  Immunologic monitoring in chronic lymphocytic leukemia.

Authors:  William G Wierda
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 4.  Chronic lymphocytic leukemia: biology and current treatment.

Authors:  Clive S Zent; Neil E Kay
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

5.  Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Authors:  Marcin Pasiarski; Jacek Rolinski; Ewelina Grywalska; Agnieszka Stelmach-Goldys; Izabela Korona-Glowniak; Stanislaw Gozdz; Iwona Hus; Anna Malm
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

Review 6.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

Review 7.  Management of patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic.

Authors:  Romeo Gabriel Mihaila
Journal:  Oncol Lett       Date:  2021-07-03       Impact factor: 2.967

Review 8.  Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.

Authors:  Pavankumar Tandra; Jairam Krishnamurthy; Vijaya Raj Bhatt; Kam Newman; James O Armitage; Mojtaba Akhtari
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

9.  Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.

Authors:  Ignacio Criado; Santiago Muñoz-Criado; Arancha Rodríguez-Caballero; Wendy G Nieto; Alfonso Romero; Paulino Fernández-Navarro; Miguel Alcoceba; Teresa Contreras; Marcos González; Alberto Orfao; Julia Almeida
Journal:  Haematologica       Date:  2017-04-06       Impact factor: 9.941

10.  Chronic Lymphocytic Leukemia-Induced Humoral Immunosuppression: A Systematic Review.

Authors:  Ewelina Grywalska; Monika Zaborek; Jakub Łyczba; Rafał Hrynkiewicz; Dominika Bębnowska; Rafał Becht; Barbara Sosnowska-Pasiarska; Jolanta Smok-Kalwat; Marcin Pasiarski; Stanisław Góźdź; Jacek Roliński; Paulina Niedźwiedzka-Rystwej
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.